Polysaccharide

Where the papers sit

10 papers from the last 6 months study polysaccharide directly · updated from PubMed 10 Oct 2026

• Bioactive Material Development

  Bioactive polysaccharide work is moving toward controlled production and structure–function design. Fermentation optimization, strain engineering, process control and artificial intelligence are being paired with structural characterization to improve mushroom and plant-derived materials. Reported applications include neuroprotection, food colloidal behavior and broader bioactivity, so no single therapeutic endpoint dominates. The recurring question is how pathway, structure and processing determine function.

  4 papers · 40%

• Gut Inflammation and Metabolism

  Plant-derived polysaccharides and gut microbial metabolites are being developed to control intestinal inflammation and metabolic injury. Aloe vera and Sanguisorba pectin address gut protection and inflammatory bowel disease, while corn-silk pectin targets MASLD through gut-metabolism regulation. Bacteroides-derived pantothenic acid extends this focus from polysaccharide action to microbiome-host metabolic signaling. Preclinical models dominate, leaving durability, causal microbial mechanisms and human efficacy unresolved.

  4 papers · 40%

• Carbohydrate Enzyme Inhibition

  Antidiabetic activity is being tied to polysaccharide structure and extraction rather than composition alone. Xyloglucan and RG-I fractions are assessed through α-amylase and α-glucosidase inhibition, with reduced glucose hydrolysis as a recurring endpoint. Extraction conditions can alter structure and potency, especially in Notopterygium franchetii. The field is moving toward structure-guided optimization of plant polysaccharides, although the evidence remains enzyme-based rather than clinical.

  2 papers · 20%